Human Bocavirus: Passenger or Pathogen in Acute Respiratory Tract Infections?

Abstract

SUMMARY Human bocavirus (HBoV) is a newly identified virus tentatively assigned to the family Parvoviridae, subfamily Parvovirinae, genus Bocavirus. HBoV was first described in 2005 and has since been detected in respiratory tract secretions worldwide. Herein we review the literature on HBoV and discuss the biology and potential clinical impact of this virus. Most studies have been PCR based and performed on patients with acute respiratory symptoms, from whom HBoV was detected in 2 to 19% of the samples. HBoV-positive samples have been derived mainly from infants and young children. HBoV DNA has also been detected in the blood of patients with respiratory tract infection and in fecal samples of patients with diarrhea with or without concomitant respiratory symptoms. A characteristic feature of HBoV studies is the high frequency of coinciding detections, or codetections, with other viruses. Available data nevertheless indicate a statistical association between HBoV and acute respiratory tract disease. We present a model incorporating these somewhat contradictory findings and suggest that primary HBoV infection causes respiratory tract symptoms which can be followed by prolonged low-level virus shedding in the respiratory tract. Detection of the virus in this phase will be facilitated by other infections, either simply via increased sample cell count or via reactivation of HBoV, leading to an increased detection frequency of HBoV during other virus infections. We conclude that the majority of available HBoV studies are limited by the sole use of PCR diagnostics on respiratory tract secretions, addressing virus prevalence but not disease association. The ability to detect primary infection through the development of improved diagnostic methods will be of great importance for future studies seeking to assign a role for HBoV in causing respiratory illnesses.

Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT

“…21,27,28,64 Studies of nasopharyngeal samples have shown persistence of HBoV1 DNA for several months. [65][66][67][68] HBoV1 seroprevalence ranges from 25% in infants younger than 1 year to 93% and 100% in children of 3 (ref. 28) to 7 (ref.…”

The impact of respiratory viruses on lung health after preterm birth

“…HBoV has also been associated with acute respiratory illnesses, predominantly among young children [131–133], and has been suggested as a potential cause of acute respiratory illnesses and recurrent wheezing episodes across several studies of preterm infants and children [134–136]. …”

Human bocavirus 1 and 3 infection in children with acute gastroenteritis in Brazil

“…The second ORF encodes for two major structural proteins (VP1 and VP2) that comprise the viral capsid. The third ORF encodes for a non-structural nuclear phosphoprotein (NP1) (Allander et al 2005, Schildgen et al 2008, Jartti et al 2012.…”